Trademarkia Logo

Canada

C$
GW PHARMACEUTICALS
REGISTERED

on 20 Sept 2022

Last Applicant/ Owned by

Jazz Pharmaceuticals Operations UK Limited

Building 730 Kent Science ParkSittingbourne, KentEngland, ME9 8AG

GB

Serial Number

1936407 filed on 17th Dec 2018

Registration Number

TMA1142330 registered on 20th Sept 2022

Registration expiry Date

20th Sept 2032

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

GW PHARMACEUTICALS

Trademark usage description

pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex Read More

Classification Information


Class [005]
Pharmaceutical and veterinary preparations and substances for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal oils for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; medicinal infusions for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type ll diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; foodstuffs for medicinal purposes, namely, plant oil for the treatment of neurological diseases and conditions such as epilepsy and paediatric epilepsy, oncology, psychiatric disorders such as mood disorders and schizophrenia, type II diabetes, inflammation, cancer pain, multiple sclerosis spasticity and neonatal hypoxic-ischemic encephalopathy; dietary supplements for humans and animals, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and post-traumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxic-ischemic encephalopathy; dietetic food and substances adapted for medical and veterinary use containing cannabinoids; food for babies; herb teas for medicinal purposes, namely for the treatment of neurological diseases and conditions, namely tuberous sclerosis complex, autism spectrum disorders, epilepsy, paediatric epilepsy, oncology, psychiatric disorders, namely anxiety, mood disorders, cognitive, bipolar disorders, schizophrenia, depression and posttraumatic stress disorder, type II diabetes, inflammation, cancer pain, MS spasticity and neonatal hypoxicischemic encephalopathy; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms namely, pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, namely, multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer and AIDS, and nausea, and secondary vomiting due to chemotherapy treatments.


Classification kind code

11

Class [031]
Agricultural and horticultural products, namely, cannabis seeds for agricultural and horticultural purposes; agricultural seeds; seedlings for plant breeding; live flowers; live plants; plant residues, namely, cannabinoid oil for animal consumption, not medicinal; fresh herbs; foodstuffs and beverage for animals containing cannabinoids, not medicinal.


Classification kind code

11

Mark Details


Serial Number

1936407

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 190
on 24th Aug 2022
Registration Pending
Submitted for opposition 191
on 24th Aug 2022
Registration Fee Notice Sent
Submitted for opposition 42
on 1st Jun 2022
Advertised
Submitted for opposition 27
on 25th Mar 2022
Approval Notice Sent
Submitted for opposition 26
on 25th Mar 2022
Approved
Submitted for opposition 22
on 18th Oct 2021
Search Recorded
Submitted for opposition 20
on 18th Oct 2021
Examiner's First Report
Submitted for opposition 31
on 21st Dec 2018
Formalized
Submitted for opposition 1
on 18th Dec 2018
Created
Submitted for opposition 30
on 17th Dec 2018
Filed